First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial
We have improved our eMediNexus Platform with a far superior user experience.
Please click here to try it
Editor-in-Chief eMediNexus – Dr KK Aggarwal
Editor-in-Chief eIMANews - Dr Ravi Wankhedkar
15th February, 2018
Should we compare ourselves with CAs, Lawyers and Architects?

Dr K K Aggarwal,Recipient of Padma Shri

Quiet often we argue that medical profession cannot be treated in isolation.
All other professions, be it law, CA, sportspersons, actors, hotels, musicians, social lecturers, astrologers may charge recklessly without doing as much, even one-tenth of doctors, with sincerity and seriousness.
But remember we are different.
We, and not they, are considered next to God. We, and not they, are social business houses.
We, and not they, are given permission to suffix Dr. before their names.
We, and not they, are bound by professional ethics.... read more


To err is human now no more true in medical practice: The Famous Dr Bawa Garba Case

Dr K K Aggarwal,Recipient of Padma Shri

A single clinical error can do away with all the good that we do as doctors. The case of Dr Hadiza Bawa-Garba, a trainee pediatrician in the NHS-UK, convicted for homicide for the death of a child from sepsis, and hounded by the General Medical Council (GMC), is every junior doctor's fear today.

Case synopsis
Jack, a 6-year-old boy with Down syndrome was referred by a GP for nausea, vomiting, and diarrhea on February 18, 2011. At 10:30 am Jack was assessed by Dr Bawa-Garba, a trainee pediatrician in the NHS-UK, who made a presumptive diagnosis of fluid depletion from gastroenteritis and gave IV fluid bolus and started maintenance fluids. The patient had a past history of repaired atrioventricular canal defect and was on enalapril..... read more

Special
Top News

WMA appeals for immediate release of jailed physician

The World Medical Association has again appealed to the Iranian authorities to release immediately and unconditionally an Iranian-born Swedish resident specialist in emergency medicine, Dr. Ahmadreza Djalali, who has been sentenced to death for the charge of “corruption on earth”. Iran’s Supreme Court rejected Dr. Djalali’s last appeal and is now reviewing the death sentence before a final decision.... read more


Dr Naresh Trehan denies any disinvestment or sale of Medanta group

From the Desk of Dr KK Aggarwal Fake News: Dr Naresh Trehan denies any disinvestment or sale of Medanta group. In a personal conversation with me he said it was a fake news. It is also false that he has any personal health issues.... read more

Practice Updates

Impella Heart Pump approved for cardiomyopathy with shock

The US FDA has expanded the approval of the Impella line of heart pumps to include heart failure associated with cardiomyopathy leading to cardiogenic shock..... read more


Many young adult cancer survivors do not seek follow-up care after treatment ends

Findings of a new study to be presented at the upcoming 2018 Cancer Survivorship Symposium in Orlando, Florida suggest that a large percentage of adolescents and young adults who have been treated for cancer do not seek follow-up care after their primary treatment ends,... read more


A new drug combination for cystic fibrosis

The US FDA has approved a new drug combination Symdeko for the treatment of cystic fibrosis for patients 12 and older who have two copies of the F508del mutation in the CFTR gene or some other mutation that responds to tezacaftor/ivacaftor. Symdeko is a combination of ivacaftor and tezacaftor available as two-tablet product.... read more


New guidelines for quantification of myocardial blood flow using PET

The Society of Nuclear Medicine and Molecular Imaging's (SNMMI) Cardiovascular Council and the American Society of Nuclear Cardiology (ASNC) have published a joint position paper “Clinical Quantification of Myocardial Blood Flow Using PET”,.... read more


USPSTF recommends against ovarian cancer screening in asymptomatic women

The USPSTF recommends against screening for ovarian cancer in asymptomatic women. (D recommendation) This recommendation applies to asymptomatic women who are not known to have a high-risk hereditary cancer syndrome..... read more


US FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients

The US Food and Drug Administration permitted marketing of the Viz.AI Contact application, a type of clinical decision support software designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in their patients.... read more

eMedi Humor
Medicolegal Corner
eMedi Quiz
1. Reassurance without medication
2. Anxiolytic therapy
3. Digoxin
4. Quinidine
5. Beta blocker therapy
Lifestyle Updates
 
Inspirational Story 1: :A Child's Love
Inspirational Story 2: The story of an ant
Ceiling the price of stents alone will not suffice
Will provide a way forward in addressing patient distrust on hospitals
 
New Delhi, 14th February 2018: Prices of expensive drug eluting cardiac stents have been further slashed by the National Pharmaceutical Pricing Authority (NPPA) and the cost of basic metallic stents have been marginally increased. After several rounds of consultation with various stakeholders, the price of drug-eluting stent (DES) have been slashed by Rs 1,710 (from Rs 29,600 to Rs 27,890) while the price of bare metal stent (BMS) has been increased by Rs 400 (from Rs 7,260 to Rs 7,660). In an order, the NPPA said that the trade margin has been capped at 8%, making the current rates valid till 31st March 2019.
 
Under the order, all manufacturers of coronary stents, selling branded or non-branded, at prices higher than the ceiling price, shall revise the price of all such stents downward not exceeding the ceiling price.
To Read More or Comment, Click Here